Aurinia Pharmaceuticals Inc. diskutieren
Aurinia Pharmaceuticals Inc.
WKN: A1W7D4 / Name: Aurinia Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
4,73 €
-0,10 %
Aurinia Pharma
(Stop Loss Kurs erreicht)
09.09.2019 Oppenheimer initiates a new Buy rating and $14 price target on Aurinia Pharmaceuticals (AUPH). Oppenheimer's analyst states that the company's 'lead asset voclosporin could become the first therapeutic approved for treatment of lupus nephritis'And those are four small cap names getting analyst 'shout outs' this Tuesday.
Kursziel geändert auf 14,0
Buy Aurinia Pharmaceuticals Inc.
Kursziel geändert auf 21,0
Buy mit Kursziel 27,0
Buy beendet
Sell mit Kursziel 15,0
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Sell Aurinia Pharmaceuticals Inc.
Sell Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Sell Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Buy Aurinia Pharmaceuticals Inc.
Neueste Beiträge
Traumtanz in Peloton Interactive Inc. diskutieren